Texcell is a research company specialized in biosafety. This Genopole business also has affiliates in Germany, the United States and Asia. In 2023, it signed a commercial agreement with GTP Bioways. Together, they aim to provide an end-to-end accompaniment offer for the development of innovative therapies. Texcell will intervene in its fields of expertise (viral tests, viral clearance and bioassays) and GTP Bioways will ensure processes development and GMP production of biopharmaceutical products.